ARUP Laboratories Adds Prosigna to Its Test Menu
March 05, 2014 13:34 ET
|
ARUP Laboratories
SALT LAKE CITY, March 5, 2014 (GLOBE NEWSWIRE) -- ARUP Laboratories announced on Monday, March 3, that it has added the Prosigna Breast Cancer Prognostic Gene Signature assay to its comprehensive...
![desc](http://www.globenewswire.com/en/Attachment/LogoDisplay/286116?filename=286116.jpg&size=2)
ARUP Laboratories Introduces New Medical Director Dr. Juan Rosai at USCAP 2014
February 27, 2014 15:45 ET
|
ARUP Laboratories
SALT LAKE CITY, Feb. 27, 2014 (GLOBE NEWSWIRE) -- ARUP Laboratories will introduce its new medical director and consultant surgical pathologist, Dr. Juan Rosai, at USCAP's 2014 Annual Meeting.
Dr....
![desc](http://www.globenewswire.com/en/Attachment/LogoDisplay/283411?filename=283411.jpg&size=2)
New Utah Research Reveals Genetic Mutation Causes PCH
February 10, 2014 18:12 ET
|
ARUP Laboratories
SALT LAKE CITY, UTAH, Feb. 10, 2014 (GLOBE NEWSWIRE) -- Breakthrough research conducted by Dr. Hunter Best, one of ARUP's medical directors and Dr. Greg Elliott from Intermountain Medical Center and...
![desc](http://www.globenewswire.com/en/Attachment/LogoDisplay/279455?filename=279455.jpg&size=2)
ARUP CEO Selected as Trustee to American Board of Pathology
December 27, 2013 13:53 ET
|
ARUP Laboratories
SALT LAKE CITY, Dec. 27, 2013 (GLOBE NEWSWIRE) -- The American Board of Pathology (ABP) and ARUP Laboratories are pleased to announce that ARUP's president and CEO, Dr. Edward Ashwood, has been...